Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

GeNeuro

GeNeuro
2006 FOUNDED
PUBLIC STATUS
11-20 EMPLOYEES
GNRO STOCK SYMBOL
$7.19 SHARE PRICE (As of Friday Closing)
Description

Developer of pharmaceutical products for disorders of the nervous system.The company is developing a product pipeline for nervous system disorders associated with the expression of pathogenic proteins of human endogenous retroviral origin (HERV), including the diseases multiple sclerosis and schizophrenia.

Website
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Biotechnology
Stock Exchange
PAR
Primary Office
  • 18, chemin des Aulx
  • Plan-les-Ouates
  • CH-1228 Geneva
  • Switzerland

+41 022 000 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore GeNeuro’s full profile, request a free trial.

GeNeuro Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$4.69 - $14.94 $105M $7.17 -$0.45 1.98K 14.7M

GeNeuro Financials Summary

In Thousands,
USD
TTM
31-Dec-2017
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
FY 2015
31-Dec-2015
Enterprise Value 68,004 68,004 121,824
Revenue 16,859 16,859 6,546 2,817
EBITDA (6,501) (6,501) (15,565) (4,975)
Net Income (6,583) (6,583) (15,600) (4,978)
Total Assets 36,434 36,434 39,734 22,701
Total Debt 0 0 193 193
Public Fundamental Data provided by Morningstar, Inc. disclaimer

GeNeuro Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore GeNeuro‘s full profile, request access.

Request full access to PitchBook

GeNeuro Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore GeNeuro‘s full profile, request access.

Request full access to PitchBook

GeNeuro Executive Team (6)

Name Title Board
Seat
Contact
Info
Miguel Payró Chief Financial Officer
Francois Curtin MD Chief Operating Officer
Alois Lang Ph.D Chief Development Officer
Herve Perron Ph.D Founder & Chief Scientific Officer
Robert Glanzman Chief Medical Officer
You’re viewing 5 of 6 executives. Get the full list »